EmergenciesNCT05818215
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
An observational study of Emergencies and Epidemic Disease, run by Pediatric Clinical Research Platform at 1 site in Switzerland.
Trial summary
A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics. Read more about this study
- Who is it for?
- Ages Up to 16 years
- Conditions the study is for
- Emergencies, Epidemic Disease, Pediatric ALL
- How many people
- 18,000 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Sep 2021to 20 Jan 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 16 years
- All sexes
- No healthy volunteers
- Child
Study population: All patients under 16 years of age with medical, surgical and traumatology emergencies attending each pediatric emergency department during the study period will be included. This also includes transfer cases from other hospitals, as well as those who leave prematurely without being seen.
Who may be able to join
- all patients
Who cannot join
- none
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Impact of the Qatar 2022 FIFA World Cup During Winter Epidemics on Paediatric Emergency Department Use and Misuse Patterns: a Multicentre, Retrospective, Population-based Study
A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics.
Read the detailed description
Earlier studies have reported contradictory relationship between major sporting events and paediatric emergency department attendance. None were conducted during an epidemic surge. The FIFA football World Cup 2022 was held for the first time in its history during the winter period in the northern hemisphere during unprecedented cumulative waves of respiratory syncitial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics.
This study aims to measure the impact of such a global major sporting events on the pattern of paediatric emergency department use and hospital admissions during a peak epidemic season in 2 tertiary hospitals. The study hypothesis was that major sporting events, even during an epidemic peak, can reduce the number of paediatric emergency department visits compared with periods without a sporting event. Major sporting events could serve as a model for identifying human behaviours and patterns leading to paediatric emergency department misuse, in order to develop public health interventions to better rationalise health-seeking behaviours.
- Being tested
- NO intervention
- Keywords
- Pediatric Emergency Medicine, Emergency Service Hospital, Pediatrics, Epidemics, Respiratory Syncytial Viruses, Influenza, Human, SARS-CoV-2, Sports
- Medical subject headings
- Emergencies, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Influenza, Human
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
NO interventionOther
NO intervention
| Study group | Role | What they receive |
|---|---|---|
| All participants | Data from electronic medical records of all patients under 16 years of age with medical, surgical and traumatology emergencies attending the paediatric emergency departments during the study period Receives: Other: NO intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
PED visits
Retrospective analysis of number of PED visits (counts).
Measured: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Secondary outcomes (7)
Triage acuity score
Retrospective analysis of number of PED visits (counts) by triage acuity score (coded using the 5-level Canadian Triage and Acuity Scale (from level 1 [resuscitation] to level 5 [nonurgent]).
Measured: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Chief complaint
Retrospective analysis of number of PED visits (counts) by chief complaints.
Measured: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Main diagnosis
Retrospective analysis of number of PED visits (counts) by main diagnosis (coded using the International Classification of Primary Care, 2nd edition [ICPC-2], and International Statistical Classification of Diseases and Related Health Problems, 10th revision [ICD-10-GM]).
Measured: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Audience
Daily television and online media audience collected by the independent, multi-platform Swiss national foundation for media research (Mediapulse AG, Bern, Switzerland).
Measured: Analysed retrospectively from October 1st, 2022 to December 31, 2022
RSV incidence
RSV-incidence estimates among children will be obtained from the anonymised Swiss RSV EpiCH multicentre database. RSV testing uses reverse-transcription polymerase chain reaction or rapid antigen test at the point of care.
Measured: Analysed retrospectively from October 1st, 2022 to December 31, 2022
Influenza incidence
Influenza-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. RSV testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care.
Measured: Analysed retrospectively from October 1st, 2022 to December 31, 2022
SARS-CoV-2 incidence
SARS-CoV-2-incidence among children visiting the PED during the study period will be obtained from the institutional electronic medical records. SARS-CoV-2 testing on nasopharyngeal swabs uses reverse-transcription polymerase chain reaction at the point of care.
Measured: Analysed retrospectively from October 1st, 2022 to December 31, 2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Apr 2023
- Study start1 Sep 2021
- Primary completion20 Jan 2023
- Study completion20 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for EmergenciesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 18,000 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pediatric Clinical Research Platform
- Sponsor type
- University, hospital or other
- Collaborators
- University of Lausanne Hospitals
- Responsible party
- Principal investigator, Johan Siebert, MD, Pediatric Clinical Research Platform
- Investigators
- Johan N Siebert, MD, Study director, Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05818215
- Sponsor's protocol ID
- FIFA World Cup Qatar 2022
- Status last verified
- Apr 2023
- First submitted
- 5 Apr 2023
- Last updated
- 18 Apr 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual Participant Data will be deidentified and the study investigators will house the data locally on secured servers at the Geneva University Hospitals. The datasets used or analysed during the current trial will be available from the corresponding author upon reasonable request. Only deidentified/anonymised data will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 18 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of the Qatar 2022 FIFA World Cup During Winter Epidemics on Paediatric Emergency Department Use and Misuse Patterns: a Multicentre, Retrospective, Population-based Study
- ClinicalTrials.gov ID
- NCT05818215
- Acronym / sponsor ID
- FIFA World Cup Qatar 2022
- Keywords
- Pediatric Emergency Medicine, Emergency Service Hospital, Pediatrics, Epidemics, Respiratory Syncytial Viruses, Influenza, Human, SARS-CoV-2, Sports
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 18,000 participants (actual)
- Lead sponsor
- Pediatric Clinical Research PlatformUniversity, hospital or other
- Collaborators
- University of Lausanne Hospitals
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 20 Jan 2023 (actual)
- Study completion
- 20 Jan 2023 (actual)
- First posted
- 18 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics.
Detailed description
Earlier studies have reported contradictory relationship between major sporting events and paediatric emergency department attendance. None were conducted during an epidemic surge. The FIFA football World Cup 2022 was held for the first time in its history during the winter period in the northern hemisphere during unprecedented cumulative waves of respiratory syncitial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemics.
This study aims to measure the impact of such a global major sporting events on the pattern of paediatric emergency department use and hospital admissions during a peak epidemic season in 2 tertiary hospitals. The study hypothesis was that major sporting events, even during an epidemic peak, can reduce the number of paediatric emergency department visits compared with periods without a sporting event. Major sporting events could serve as a model for identifying human behaviours and patterns leading to paediatric emergency department misuse, in order to develop public health interventions to better rationalise health-seeking behaviours.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All participants | – | Other: NO interventionData from electronic medical records of all patients under 16 years of age with medical, surgical and traumatology emergencies attending the paediatric emergency departments during the study period |
Who may qualify
- Ages
- Up to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- All patients under 16 years of age with medical, surgical and traumatology emergencies attending each pediatric emergency department during the study period will be included. This also includes transfer cases from other hospitals, as well as those who leave prematurely without being seen.
Key inclusion criteria (1 listed)
- all patients
Key exclusion criteria (1 listed)
- none
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| NO interventionNO intervention | Other | All participants |
Primary outcome
PED visits
Time frame: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Retrospective analysis of number of PED visits (counts).
7 secondary outcomes
Triage acuity score
Time frame: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Chief complaint
Time frame: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Main diagnosis
Time frame: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022
Audience
Time frame: Analysed retrospectively from October 1st, 2022 to December 31, 2022
RSV incidence
Time frame: Analysed retrospectively from October 1st, 2022 to December 31, 2022
Influenza incidence
Time frame: Analysed retrospectively from October 1st, 2022 to December 31, 2022
SARS-CoV-2 incidence
Time frame: Analysed retrospectively from October 1st, 2022 to December 31, 2022
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Apr 2023.
- Individual participant dataSharing planned: Yes. Individual Participant Data will be deidentified and the study investigators will house the data locally on secured servers at the Geneva University Hospitals. The datasets used or analysed during the current trial will be available from the corresponding author upon reasonable request. Only deidentified/anonymised data will be shared.
Related trials for Emergencies
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
Not yet recruiting
Miniature In-line Respirator
Brain Death, Respiration, Artificial
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
RecruitingObservational study
AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis
Complicated Diverticulitis, Acute Diverticulitis
Recruiting
Developing a Support Application for Food Pantries (SAFPAS) to Improve Client Access to Healthy Foods & Enhance Emergency Preparedness
Improving Healthy Food Access in Food Insecurity Populations in Normal and Emergency Situations
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Johan N Siebert, MD study director
Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Emergencies and Epidemic Disease, run by Pediatric Clinical Research Platform at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
PED visits (time frame: Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2023.